Literature DB >> 17372201

Saposin B is the dominant saposin that facilitates lipid binding to human CD1d molecules.

Weiming Yuan1, Xiaoyang Qi, Pansy Tsang, Suk-Jo Kang, Petr A Illarionov, Petr A Illaniorov, Gurdyal S Besra, Jenny Gumperz, Peter Cresswell.   

Abstract

CD1d molecules bind lipid antigens in the endocytic pathway, and access to the pathway is important for the development of CD1d-restricted natural killer T (NKT) cells. Saposins, derived from a common precursor, prosaposin, are small, heat-stable lysosomal glycoproteins required for lysosomal degradation of sphingolipids. Expression of prosaposin is required for efficient lipid binding and recognition of human CD1d molecules by NKT cells. Despite high sequence homology among the four saposins, they have different specificities for lipid substrates and different mechanisms of action. To determine the saposins involved in promoting lipid binding to CD1d, we expressed prosaposin deletion mutants lacking individual saposins in prosaposin-negative, CD1d-positive cells. No individual saposin proved to be absolutely essential, but the absence of saposin B resulted in the lowest recognition of alpha-galactosylceramide by NKT cells. When recombinant exogenous saposins were added to the prosaposin-negative cells, saposin B was the most efficient in restoring CD1d recognition. Saposin B was also the most efficient in mediating alpha-galactosylceramide binding to recombinant plate-bound CD1d and facilitating NKT cell activation. Saposin B could also mediate lipid binding to soluble CD1d molecules in a T cell-independent assay. The optimal pH for saposin B-mediated lipid binding to CD1d, pH 6, is higher than that of lysosomes, suggesting that saposin B may facilitate lipid binding to CD1d molecules throughout the endocytic pathway.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17372201      PMCID: PMC1838443          DOI: 10.1073/pnas.0700617104

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  44 in total

1.  Gaucher's disease: deficiency of 'acid' -glucosidase and reconstitution of enzyme activity in vitro.

Authors:  M W Ho; J S O'Brien
Journal:  Proc Natl Acad Sci U S A       Date:  1971-11       Impact factor: 11.205

2.  Functional human saposins expressed in Escherichia coli. Evidence for binding and activation properties of saposins C with acid beta-glucosidase.

Authors:  X Qi; T Leonova; G A Grabowski
Journal:  J Biol Chem       Date:  1994-06-17       Impact factor: 5.157

3.  Activator protein required for the enzymatic hydrolysis of cerebroside sulfate. Deficiency in urine of patients affected with cerebroside sulfatase activator deficiency and identity with activators for the enzymatic hydrolysis of GM1 ganglioside and globotriaosylceramide.

Authors:  S C Li; H Kihara; S Serizawa; Y T Li; A L Fluharty; J S Mayes; L J Shapiro
Journal:  J Biol Chem       Date:  1985-02-10       Impact factor: 5.157

4.  Editing of CD1d-bound lipid antigens by endosomal lipid transfer proteins.

Authors:  Dapeng Zhou; Carlos Cantu; Yuval Sagiv; Nicolas Schrantz; Ashok B Kulkarni; Xiaoyang Qi; Don J Mahuran; Carlos R Morales; Gregory A Grabowski; Kamel Benlagha; Paul Savage; Albert Bendelac; Luc Teyton
Journal:  Science       Date:  2003-12-18       Impact factor: 47.728

5.  Direct measurement of antigen binding properties of CD1 proteins using fluorescent lipid probes.

Authors:  Jin S Im; Karl O A Yu; Petr A Illarionov; Kenneth P LeClair; James R Storey; Malcolm W Kennedy; Gurdyal S Besra; Steven A Porcelli
Journal:  J Biol Chem       Date:  2003-10-09       Impact factor: 5.157

6.  Lipid-protein interactions: biosynthetic assembly of CD1 with lipids in the endoplasmic reticulum is evolutionarily conserved.

Authors:  Jang-June Park; Suk-Jo Kang; A Dharshan De Silva; Aleksandar K Stanic; Giulia Casorati; David L Hachey; Peter Cresswell; Sebastian Joyce
Journal:  Proc Natl Acad Sci U S A       Date:  2004-01-13       Impact factor: 11.205

7.  Mutation in saposin D domain of sphingolipid activator protein gene causes urinary system defects and cerebellar Purkinje cell degeneration with accumulation of hydroxy fatty acid-containing ceramide in mouse.

Authors:  Junko Matsuda; Makiko Kido; Keiko Tadano-Aritomi; Ineo Ishizuka; Kumiko Tominaga; Kazunori Toida; Eiji Takeda; Kunihiko Suzuki; Yasuhiro Kuroda
Journal:  Hum Mol Genet       Date:  2004-09-02       Impact factor: 6.150

8.  Saposins facilitate CD1d-restricted presentation of an exogenous lipid antigen to T cells.

Authors:  Suk-Jo Kang; Peter Cresswell
Journal:  Nat Immunol       Date:  2004-01-11       Impact factor: 25.606

9.  Saposin C is required for lipid presentation by human CD1b.

Authors:  Florian Winau; Vera Schwierzeck; Robert Hurwitz; Natascha Remmel; Peter A Sieling; Robert L Modlin; Steven A Porcelli; Volker Brinkmann; Masahiko Sugita; Konrad Sandhoff; Stefan H E Kaufmann; Ulrich E Schaible
Journal:  Nat Immunol       Date:  2004-01-11       Impact factor: 25.606

Review 10.  CD1: antigen presentation and T cell function.

Authors:  Manfred Brigl; Michael B Brenner
Journal:  Annu Rev Immunol       Date:  2004       Impact factor: 28.527

View more
  52 in total

Review 1.  Lipid antigens in immunity.

Authors:  C Marie Dowds; Sabin-Christin Kornell; Richard S Blumberg; Sebastian Zeissig
Journal:  Biol Chem       Date:  2014-01       Impact factor: 3.915

Review 2.  Anti-tumor potential of type-I NKT cells against CD1d-positive and CD1d-negative tumors in humans.

Authors:  Leonid S Metelitsa
Journal:  Clin Immunol       Date:  2010-11-20       Impact factor: 3.969

3.  Molecular imaging of membrane interfaces reveals mode of beta-glucosidase activation by saposin C.

Authors:  Jean-René Alattia; James E Shaw; Christopher M Yip; Gilbert G Privé
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-22       Impact factor: 11.205

Review 4.  Invariant natural killer T cells in adipose tissue: novel regulators of immune-mediated metabolic disease.

Authors:  M Rakhshandehroo; E Kalkhoven; M Boes
Journal:  Cell Mol Life Sci       Date:  2013-07-09       Impact factor: 9.261

Review 5.  Optimizing NKT cell ligands as vaccine adjuvants.

Authors:  Leandro J Carreño; Shalu Sharma Kharkwal; Steven A Porcelli
Journal:  Immunotherapy       Date:  2014       Impact factor: 4.196

6.  Stimulation of a shorter duration in the state of anergy by an invariant natural killer T cell agonist enhances its efficiency of protection from type 1 diabetes.

Authors:  R Tohn; H Blumenfeld; S M M Haeryfar; N Veerapen; G S Besra; S A Porcelli; T L Delovitch
Journal:  Clin Exp Immunol       Date:  2011-03-01       Impact factor: 4.330

Review 7.  CD1 mediated T cell recognition of glycolipids.

Authors:  Dirk M Zajonc; Mitchell Kronenberg
Journal:  Curr Opin Struct Biol       Date:  2007-10-24       Impact factor: 6.809

8.  Regulation of CD1 antigen-presenting complex stability.

Authors:  Artur N Odyniec; Duarte C Barral; Salil Garg; Raju V Tatituri; Gurdyal S Besra; Michael B Brenner
Journal:  J Biol Chem       Date:  2010-02-04       Impact factor: 5.157

Review 9.  Lipid and glycolipid antigens of CD1d-restricted natural killer T cells.

Authors:  Manjunatha M Venkataswamy; Steven A Porcelli
Journal:  Semin Immunol       Date:  2009-11-27       Impact factor: 11.130

10.  Kinetics and cellular site of glycolipid loading control the outcome of natural killer T cell activation.

Authors:  Jin S Im; Pooja Arora; Gabriel Bricard; Alberto Molano; Manjunatha M Venkataswamy; Ian Baine; Elliot S Jerud; Michael F Goldberg; Andres Baena; Karl O A Yu; Rachel M Ndonye; Amy R Howell; Weiming Yuan; Peter Cresswell; Young-Tae Chang; Petr A Illarionov; Gurdyal S Besra; Steven A Porcelli
Journal:  Immunity       Date:  2009-06-19       Impact factor: 31.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.